Planta Med 2005; 71(11): 1071-1072
DOI: 10.1055/s-2005-873111
Letter
© Georg Thieme Verlag KG Stuttgart · New York

Pyrrole Carboxamidine Tryptase Inhibitors from Leptonychia pubescens

Lay Kien Yang1 , Sok Peng Ng1 , Horst Flotow1 , K. Yoganathan1 , B. O. Daramola2 , D. Doel Soejarto3 , Antony D. Buss1 , Mark S. Butler1
  • 1MerLion Pharmaceuticals, Singapore
  • 2Forest Research Institute, Ibadan, Nigeria
  • 3Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, Chicago, USA
Weitere Informationen

Publikationsverlauf

Received: March 14, 2005

Accepted: May 18, 2005

Publikationsdatum:
15. September 2005 (online)

Preview

Abstract

The root and stem bark extracts of a Nigerian sample of Leptonychia pubescens Keay (Sterculiaceae) were found to inhibit the serine protease tryptase, a potential therapeutic target for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Bioassay-guided isolation led to the identification of 1-β-ribofuranosylbrunfelsamidine as the active component with a tryptase IC50 of 3 μM. Brunfelsamidine was also isolated, but was only weakly active.

References

Mark S. Butler

MerLion Pharmaceuticals

1 Science Park Road

The Capricorn #05-01

Singapore Science Park II

Singapore 117528

Telefon: +65-6829-5611

Fax: +65-6829-5601

eMail: mark@merlionpharma.com